TY  - JOUR 
AU  - Caballero-Camino, Francisco J
AU  - Rivilla, Ivan
AU  - Herráez Aguilar, Elisa
AU  - Briz Sánchez, Oscar
AU  - Santos-Laso, Alvaro
AU  - Izquierdo-Sanchez, Laura
AU  - Lee-Law, Pui Y
AU  - Rodrigues, Pedro M
AU  - Munoz-Garrido, Patricia
AU  - Jin, Sujeong
AU  - Peixoto, Estanislao
AU  - Richard, Seth
AU  - Gradilone, Sergio A
AU  - Perugorria, Maria J
AU  - Esteller, Manel
AU  - Bujanda, Luis
AU  - García Marín, José Juan
AU  - Banales, Jesus M
AU  - Cossío, Fernando P
PY  - 2021
SN  - 1527-3350 | 0270-9139
UR  - http://hdl.handle.net/10366/169121
AB  - [EN]Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of symptomatic biliary cysts. Current surgical and pharmacological approaches are ineffective, and liver transplantation represents the only curative...
LA  - eng
PB  - John Wiley & Sons
KW  - polycystic liver disease
KW  - ursodeoxycholic acid
KW  - histone deacetylase 6
KW  - pharmacology
KW  - therapy
KW  - Liver
KW  - Random Allocation
KW  - Apoptosis
KW  - Ursodeoxycholic Acid
KW  - Rats
KW  - Bile Acids and Salts
KW  - Animals
KW  - Liver Diseases
KW  - Cysts
KW  - Bile Ducts
KW  - Cell Proliferation
TI  - Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
DO  - 10.1002/hep.31216
T2  - Hepatology (Baltimore, Md.)
VL  - 73
M2  - 186
ER  -